Loading patent…
AssigneesInstitut Pasteur, Universite Pierre Et Marie Curie (Paris 6), Centre National De La Recherche Scientifique
InventorsNicolas Wolfe, Monique Lafon, Nicolas Babault
Estimating the term…
The application provides products, which may trigger pro-apoptotic or pro-death effects on neoplastic cells and/or tissues of the human nervous system, more particularly on neoplastic cells and/or tissues of the human CNS. The products of the application can be used as anti-proliferative or tumoricid agents in the treatment and/or palliation and/or prevention of neoplasms of the human nervous system, more particularly of glioblastoma or brain stem glioma. Therefore, the application also relates to compositions, such as pharmaceutical compositions or drugs, which comprise at least one of said products, as well as to the biotechnological and medical applications of said products and compositions.
A peptide of less than 30 amino acids, which comprises the RETEV motif, wherein the amino acid sequence of said peptide comprises at least one of SEQ ID NOs:
The peptide of any one of the preceding claims, the amino acid sequence of which comprises or consists of at least one of SEQ ID NOs:
The peptide of any one of the preceding claims, the amino acid sequence of which comprises or consists of SEQ ID NO:
Dependencies are inferred from the claim text.